Your session is about to expire
← Back to Search
Cancer Vaccine
HPV Vaccine Communication Strategies for Adolescent Vaccine Uptake
N/A
Recruiting
Led By William A Calo, PhD, JD, MPH
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up twelve months
Awards & highlights
Study Summary
This trial will test the effectiveness of two HPV vaccination communication interventions (Announcement Approach Training and recall notices) delivered through the ECHO Model, compared to a control group.
Who is the study for?
This trial is for family medicine or pediatric clinics in Pennsylvania with at least 100 active patients aged 11-14. It's also for parents or guardians of adolescents aged 11-17 who have not started the HPV vaccine and receive care at participating clinics. Clinics outside PA, those involved in recent HPV research, or patients already vaccinated are excluded.Check my eligibility
What is being tested?
The trial tests two strategies to increase HPV vaccination rates delivered via ECHO: one provides Announcement Approach training to providers; the other adds recall notices for parents who decline vaccines. The effectiveness of these interventions compared to a control group will be evaluated.See study design
What are the potential side effects?
Since this trial focuses on communication strategies rather than medical treatments, there are no direct side effects from interventions like you would expect with drugs or vaccines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ twelve months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~twelve months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HPV vaccination (≥1 dose), 11-14 year olds at 12 months
Secondary outcome measures
HPV vaccination (completion), 11-14 year olds at 12 months
HPV vaccination (completion), 11-14 year olds at 3 months
HPV vaccination (completion), 11-14 year olds at 6 months
+10 moreOther outcome measures
Meningococcal vaccination (≥1 dose), 11-14 year olds
Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination, 11-14 year olds
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: HPV ECHO+Experimental Treatment3 Interventions
Clinics randomly assigned to this arm will receive the HPV ECHO intervention plus a systems communication strategy to deliver recall notices to parents who initially decline HPV vaccination. This arm includes 12 primary care clinics in Pennsylvania.
Group II: HPV ECHOExperimental Treatment2 Interventions
Clinics randomly assigned to this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. The intervention has a curriculum of 10 sessions focused on the evidence-based Announcement Approach. Sessions will be 60 minutes in duration and held every other weekly for 4 months at regularly scheduled times.
Group III: ControlActive Control1 Intervention
Clinics randomly assigned to this arm will receive no ECHO interventions. This arm includes 12 primary care clinics in Pennsylvania.
Find a Location
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
494 Previous Clinical Trials
2,798,806 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,926,162 Total Patients Enrolled
William A Calo, PhD, JD, MPHPrincipal InvestigatorPenn State College of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have started the HPV vaccination series.I am not the parent or guardian of a child aged 11-17.I am between 11 and 14 years old.I am the parent or guardian of a child aged 11-17.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: HPV ECHO+
- Group 3: HPV ECHO
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for participants in this trial?
"According to information available on clinicaltrials.gov, this trial is actively seeking potential participants. The study was initially listed on May 1st 2021 and the most recent edit occurred April 29th 2022."
Answered by AI
How many research participants have been recruited thus far for this investigation?
"Affirmative, the information available on clinicaltrials.gov verifies that this medical trial is presently recruiting patients. It was initially advertised on May 1st 2021 and modified most recently on April 29th 2022. The study requires 36 volunteers to be recruited from one site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger